Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
Press releases 13 Jul 2026 DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security
Press releases 13 Jul 2026 DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals
Press releases 8 Jul 2026 Brazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment developed by Serum Institute of India
Press releases 22 Jun 2026 More than 50 organizations urge MEPs to back access provisions in the EU’s next research programme
Press releases 12 Jun 2026 DRC approves the use of acoziborole, a breakthrough one-day oral treatment against sleeping sickness
Press releases 8 Jun 2026 DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need
Press releases 12 May 2026 DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai
Press releases 27 Apr 2026 Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients
Press releases 4 Mar 2026 Pandemic preparedness: Novo Nordisk Foundation renews its support to DNDi and THSTI to continue the development of broad-spectrum antivirals
Press releases 27 Feb 2026 Acoziborole Winthrop, developed by DNDi and Sanofi, receives European Medicines Agency positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness
Press releases 20 Feb 2026 DNDi welcomes GHIT support for lead identification of a novel chemical series in the Eisai-led Chagas disease project
Press releases 10 Feb 2026 DNDi and Dubai Health launch Middle East partnership to advance research and training in neglected diseases
Press releases 27 Nov 2025 International seminar explores the development of treatments for dengue for populations not covered by vaccines
Press releases 10 Nov 2025 COP 30: The climate crisis is also a crisis for neglected diseases, warns DNDi
